IGC Pharma enrols two subjects in Alzheimer's therapy trial at Neurostudies

Retrieved on: 2024-05-29 16:41:38

Tags for this article:

Click the tags to see associated articles and topics

IGC Pharma enrols two subjects in Alzheimer's therapy trial at Neurostudies. View article details on hiswai:

Excerpt

Evaluating the efficacy of IGC-AD1 for treating agitation in Alzheimer's disease is the trial's primary objective. May 29, 2024.

Article found on: www.clinicaltrialsarena.com